Latest market price
3.58
+0.14+4.07%
OverviewShort InterestFilings
RLMDQT27Relmada Therapeutics, Inc.·NASDAQ
3.58+4.07%

Latest SEC Filings

Form category
DescriptionFilingDocument
Sep 11, 20264Statement of changes in beneficial ownership
Sep 11, 20264Statement of changes in beneficial ownership
Sep 08, 20268-KCurrent report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 28, 20268-KCurrent report
Jun 22, 2026SC 13GBeneficial ownership statement (passive)
Jun 18, 2026S-8Registration of employee benefit securities
Jun 09, 2026SC 13GBeneficial ownership statement (passive)
May 28, 20268-KCurrent report
May 13, 2026S-3ASRS-3ASR
May 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
May 04, 2026SC 13GBeneficial ownership statement (passive)
Apr 17, 2026DEFA14AAdditional proxy soliciting materials
Apr 17, 2026DEF 14ADefinitive proxy statement
Apr 09, 2026EFFECTNotice of effectiveness
Apr 09, 2026424B3Prospectus
Apr 06, 2026PRE 14APreliminary proxy statement
Apr 03, 2026S-3Shelf registration statement
Mar 20, 20268-KCurrent report
Mar 19, 202610-KAnnual report
#1 / 25 of 257
Page
▼
/ 11